A study led by researchers at WIMR has, for the first time, demonstrated how CD47 – a cell surface protein – drives biological dysfunctions in the body, such as decreased circulation and poor metabolic homeostasis, both of which worsen with age. Researchers hope developing therapies that target CD47 will significantly reduce the impact these health issues have on older...
